SEC Comment Letter 0000000000-24-012785 to Dare Bioscience, Inc. (DARE) (CIK 0001401914) (DARE)
Dare Bioscience, Inc. (DARE) (CIK 0001401914)
Date: Nov. 19, 2024 · CIK: 0001401914 · Accession: 0000000000-24-012785
AI Filing Summary & Sentiment
File numbers found in text: 333-283280
Letter
November 19, 2024 Sabrina Martucci Johnson Chief Executive Officer Daré Bioscience, Inc. 3655 Nobel Drive, Suite 260 San Diego, California 92122 Re:Daré Bioscience, Inc. Registration Statement on Form S-1 Filed November 15, 2024 File No. 333-283280 Dear Sabrina Martucci Johnson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Edwin Astudillo, Esq.
Show Raw Text
November 19, 2024
Sabrina Martucci Johnson
Chief Executive Officer
Daré Bioscience, Inc.
3655 Nobel Drive, Suite 260
San Diego, California 92122
Re:Daré Bioscience, Inc.
Registration Statement on Form S-1
Filed November 15, 2024
File No. 333-283280
Dear Sabrina Martucci Johnson:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Edwin Astudillo, Esq.